Total Funding
42
Total FundingGrant raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
InteRNA Technologies provides drug discovery and development services.
Roel Schaapveld: Chief Executive Officer- Gabriele Campi: Board Member
About the Company
InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatment
Nijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investors
participating in this round include the 'Innovation & Investment Fund Gelderland', managed by PPM Oost and several business angels.
